4Sureshbabu W,Mawlawi 0. PET/CT imaging artifacts[J]. J Nucl Med Technol,2005,33(3):156-161.
5Kamel AI,Ali TF,Tawab MA. Potential impact of PET/CT on the initialstaging of lymphoma[J]. Egyptian J Rad Nuclear Medicine,2013,44(2):331-338.
6la Fougere C,Hundt W,Brockel N,et al.Yalue of PET/CT versus PETand CT performed as separate investigations in patients with Hodgkin'sdisease and non-Hodgkin's lymphoma[J]. Eur J Nucl Med Mol Imaging,2006,33(12):1417-1425.
7Hutchings M,Barrington SF. PET/CT for therapy response assessment inlymphoma[J]. J Nucl Med,2009,50(Suppl 1) :21-30.
10Pelosi E,Pregno P, Penna D,et al. Role of whole-body [18F] fluorodeoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkinand aggressive non Hodgkin lymphoma [J]. Radiol Med ,2008,113 (4):578-590.
